{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T06:32:41Z","timestamp":1774074761376,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,5,12]],"date-time":"2012-05-12T00:00:00Z","timestamp":1336780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s12031-012-9785-6","type":"journal-article","created":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T15:07:45Z","timestamp":1336748865000},"page":"660-666","source":"Crossref","is-referenced-by-count":9,"title":["PYK-2 is Tyrosine Phosphorylated after Activation of Pituitary Adenylate Cyclase Activating Polypeptide Receptors in Lung Cancer Cells"],"prefix":"10.1007","volume":"48","author":[{"given":"Terry W.","family":"Moody","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Di Florio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert T.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,12]]},"reference":[{"key":"9785_CR1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/bj3250375","volume":"325","author":"SL Bellis","year":"1997","unstructured":"Bellis SL, Perotta JA, Curtis MS, Turner CE (1997) Adhesion of fibroblasts to fibronectin stimulates both serine and tyrosine phosphorylation of paxillin. Biochem J 325:375\u2013381","journal-title":"Biochem J"},{"key":"9785_CR2","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1128\/MCB.15.2.954","volume":"15","author":"MB Calaib","year":"1995","unstructured":"Calaib MB, Polte TR, Hanks SK (1995) Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity. Mol Cell Biol 15:954\u2013963","journal-title":"Mol Cell Biol"},{"key":"9785_CR3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/383547a0","volume":"383","author":"I Dikic","year":"1996","unstructured":"Dikic I, Tokiwa G, Lev S, Courtneidge SA, Schlessinger J (1996) A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 383:547\u2013550","journal-title":"Nature"},{"key":"9785_CR4","doi-asserted-by":"crossref","first-page":"10976","DOI":"10.1158\/0008-5472.CAN-07-2667","volume":"67","author":"J Halder","year":"2007","unstructured":"Halder J, Lin YG, Merritt WM, Spannuth WA, Nick AM, Honda T, Kamat AA, Han LY, Kim TJ, Lu C, Tari AM, Bornmann W, Fernandez A, Lopez-Berestein G, Sood AK (2007) Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma. Cancer Res 67:10976\u201310983","journal-title":"Cancer Res"},{"key":"9785_CR5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/B978-0-12-386041-5.00005-4","volume":"288","author":"JE Hall","year":"2011","unstructured":"Hall JE, Fu W, Schaller MD (2011) Focal adhesion kinase: exploring FAK structure to gain insight into function. Int Rev Cell Mol Biol 288:185\u2013225","journal-title":"Int Rev Cell Mol Biol"},{"key":"9785_CR6","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0896-6273(92)90101-I","volume":"8","author":"T Ishihara","year":"1992","unstructured":"Ishihara T, Shigemoto R, Mori K, Takahashi K, Nagata S (1992) Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 8:811\u2013819","journal-title":"Neuron"},{"key":"9785_CR7","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1210\/en.2003-1433","volume":"145","author":"K Kuwabara","year":"2004","unstructured":"Kuwabara K, Nakaoka T, Sato K, Nishishita T, Sasaki T, Yamashita N (2004) Differential regulation of cell migration and proliferation through proline-rich tyrosine kinase 2 in endothelial cells. Endocrinology 145:3324\u20133330","journal-title":"Endocrinology"},{"key":"9785_CR8","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/0196-9781(90)90153-V","volume":"11","author":"M Lee","year":"1990","unstructured":"Lee M, Jensen RT, Bepler G, Korman LY, Moody TW (1990) Vasoactive intestinal polypeptide binds with high affinity to non-small cell lung cancer cells and elevates cAMP\u201d levels. Peptides 11:1205\u20131210","journal-title":"Peptides"},{"key":"9785_CR9","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/376737a0","volume":"376","author":"S Lev","year":"1995","unstructured":"Lev S, Moreno H, Martinez R, Canoll P, Peles E, Musacchio JM, Plowman GD, Rudy B, Schlessinger JA (1995) Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions. Nature 376:737\u2013745","journal-title":"Nature"},{"key":"9785_CR10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1517\/14728220903473194","volume":"14","author":"CA Lipinski","year":"2010","unstructured":"Lipinski CA, Loftus JC (2010) Targeting Pyk2 for therapeutic intervention. Expert Opin Ther Targets 14:95\u2013108","journal-title":"Expert Opin Ther Targets"},{"key":"9785_CR11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1593\/neo.04712","volume":"7","author":"CA Lipinski","year":"2005","unstructured":"Lipinski CA, Tran NL, Menashi E, Rohl C, Kloss J, Bay RC, Berens ME, Loftus JC (2005) The tyrosine kinase PYK2 promotes migration and invasion of glioma cells. Neoplasia 7:435\u2013445","journal-title":"Neoplasia"},{"key":"9785_CR12","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1158\/1535-7163.MCT-06-0476","volume":"6","author":"TJ Liu","year":"2007","unstructured":"Liu TJ, LaFortune T, Honda T, Ohmori O, Hatakeyama S, Meyer T, Jackson D, deGroot J, Yung WK (2007) Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo. Mol Cancer Ther 6:1357\u20131367","journal-title":"Mol Cancer Ther"},{"key":"9785_CR13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0014-5793(93)81668-P","volume":"334","author":"EM Lutz","year":"1993","unstructured":"Lutz EM, Sheward WJ, West KM, Morrow JA, Harmar AJ (1993) The VIP2 receptor molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett 334:3\u20138","journal-title":"FEBS Lett"},{"key":"9785_CR14","doi-asserted-by":"crossref","first-page":"9749","DOI":"10.1074\/jbc.M109.043117","volume":"285","author":"V May","year":"2010","unstructured":"May V, Lutz E, MacKenzie C, Schutz K, Dozark K, Braas K (2010) Pituitary adenylate cyclase-activating polypeptide (PACAP)\/PAC1HOP1 receptor activation coordinates multiple neurotophic signaling pathways. J Biol Chem 285:9749\u20139761","journal-title":"J Biol Chem"},{"key":"9785_CR15","first-page":"493","volume-title":"Handbook of biologically active peptides","author":"TW Moody","year":"2006","unstructured":"Moody TW, Jensen RT (2006) VIP and PACAP as autocrine growth factors in breast and lung cancer. In: Kastin A (ed) Handbook of biologically active peptides. Elsevier, Amsterdam, pp 493\u2013498"},{"key":"9785_CR16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1017994722130","volume":"68","author":"TW Moody","year":"2001","unstructured":"Moody TW, Leyton J, Chan D, Brenneman DC, Fridkin M, Gelber E, Levy A, Gozes I (2001) VIP receptor antagonists potentiate the action of chemotherapeutic drugs on breast cancer cells. Breast Cancer Res Treat 68:55\u201364","journal-title":"Breast Cancer Res Treat"},{"key":"9785_CR17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0167-0115(02)00196-9","volume":"109","author":"TW Moody","year":"2002","unstructured":"Moody TW, Leyton J, Casibang M, Pisegna J, Jensen RT (2002) PACAP-27 tyrosine phosphorylates mitogen activated protein kinase and increases VEGF mRNAs in human lung cancer cells. Regul Pept 109:135\u2013140","journal-title":"Regul Pept"},{"key":"9785_CR18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2174\/1381612033391621","volume":"9","author":"TW Moody","year":"2003","unstructured":"Moody TW, Chan D, Fahrenkrug J, Jensen RT (2003a) Neuropeptides as autocrine growth factors in cancer cells. Curr Pharm Des 9:495\u2013509","journal-title":"Curr Pharm Des"},{"key":"9785_CR19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0196-9781(02)00290-5","volume":"24","author":"TW Moody","year":"2003","unstructured":"Moody TW, Hill JM, Jensen RT (2003b) VIP as a trophic factor in the CNS and cancer cells. Peptides 24:163\u2013177","journal-title":"Peptides"},{"key":"9785_CR20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12031-011-9639-7","volume":"46","author":"TW Moody","year":"2012","unstructured":"Moody TW, Leyton J, Jensen RT (2012a) Pituitary adenylate cyclase-activating polypeptide causes increased tyrosine phosphorylation of focal adhesion kinase and paxillin. J Mol Neurosci 46:68\u201374","journal-title":"J Mol Neurosci"},{"key":"9785_CR21","doi-asserted-by":"crossref","unstructured":"Moody TW, Osefo N, Nuche-Berenguer B, Ridnour L, Wink D, Jensen RT (2012b) Pituitary adenylate cyclase activating polypeptide causes tyrosine phosphorylation of the EGF receptor in lung cancer cells. J Pharm Exp Ther [Epub ahead of print]","DOI":"10.1124\/jpet.111.190033"},{"key":"9785_CR22","doi-asserted-by":"crossref","first-page":"19008","DOI":"10.1074\/jbc.M300832200","volume":"278","author":"A Pace","year":"2003","unstructured":"Pace A, Garcia-Marin LJ, Tapia JA, Bragado MJ, Jensen RT (2003) Phosphospecific site tyrosine phosphorylation of p125FAK and proline-rich kinase 2 is differentially regulated by cholecystokinin receptor type A activation in pancreatic acini. J Biol Chem 278:19008\u201319016","journal-title":"J Biol Chem"},{"key":"9785_CR23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0303-7207(01)00667-0","volume":"186","author":"A Picascia","year":"2002","unstructured":"Picascia A, Stanzione R, Chieffi P, Kisslinger A, Dikic I, Tramontano D (2002) Proline-rich tyrosine kinase 2 regulates proliferation and differentiation of prostate cells. Mol Cell Endocrinol 186:81\u201387","journal-title":"Mol Cell Endocrinol"},{"key":"9785_CR24","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.1073\/pnas.90.13.6345","volume":"90","author":"J Pisegna","year":"1993","unstructured":"Pisegna J, Wank SA (1993) Molecular cloning and functional expression of the pituitary adenylate cyclase activating polypeptide type I receptor. Proc Natl Acad Sci USA 90:6345\u20136349","journal-title":"Proc Natl Acad Sci USA"},{"key":"9785_CR25","doi-asserted-by":"crossref","first-page":"17267","DOI":"10.1074\/jbc.271.29.17267","volume":"271","author":"JR Pisegna","year":"1996","unstructured":"Pisegna JR, Wank SA (1996) Cloning and characterization of the signal transduction of four splice variants of the human pituitary adenylate cyclase activating polypeptide receptor. Evidence for dual coupling to adenylate cyclase and phospholipase C. J Biol Chem 271:17267\u201317274","journal-title":"J Biol Chem"},{"key":"9785_CR26","first-page":"3105","volume":"60","author":"JC Reubi","year":"2000","unstructured":"Reubi JC, Laderach U, Waser B, Gebbers JD, Robberecht P, Laissue JA (2000) Vasoactive intestinal peptide\/pituitary adenylate cyclase activating polypeptide receptor subtypes in human tumors and their tissues of origin. Cancer Res 60:3105\u20133112","journal-title":"Cancer Res"},{"key":"9785_CR27","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1158\/0008-5472.CAN-07-5155","volume":"68","author":"WG Roberts","year":"2008","unstructured":"Roberts WG, Ung E, Whalen P, Cooper B, Hulford C, Autry C, Richter D, Emerson E, Lin J, Kath J, Coleman K, Yao L, Martinez-Alsina L, Lorenzen M, Berliner M, Luzzio M, Patel N, Schmitt E, LaGreca S, Jani J, Wessel M, Marr E, Griffor M, Vasdos F (2008) Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271. Cancer Res 68:1935\u20131944","journal-title":"Cancer Res"},{"key":"9785_CR28","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1038\/sj.onc.1210819","volume":"27","author":"S Rolle","year":"2008","unstructured":"Rolle S, Grosse R, Buech T, Chubanov V, Gudermann T (2008) Essential role of Pyk2 and Src kinase activation in neuropeptide-induced proliferation of small cell lung cancer cells. Oncogene 27:1737\u20131748","journal-title":"Oncogene"},{"key":"9785_CR29","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1073\/pnas.89.1.192","volume":"89","author":"MD Schaller","year":"1992","unstructured":"Schaller MD, Borgman CA, Cobb BS, Vaines RR, Reynolds AB, Parsons JT (1992) P125FAK, a structurally distinctive protein tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci USA 89:192\u2013196","journal-title":"Proc Natl Acad Sci USA"},{"key":"9785_CR30","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm.1790","volume":"14","author":"K Sheddon","year":"2008","unstructured":"Shedden K, Taylor JM, Enkemann SA, Tsao MS, Yeatman TJ, Gerald WL, Eschrich S, Jurisica I, Giordano TJ, Misek DE, Chang AC, Zhu CQ, Strumpf D, Hanash S, Shepherd FA, Ding K, Seymour L, Naoki K, Pennell N, Weir B, Verhaak R, Ladd-Acosta C, Golub T, Gruidl M, Sharma A, Szoke J, Zakowski M, Rusch V, Kris M, Viale A, Motoi N, Travis W, Conley B, Seshan VE, Meyerson M, Kuick R, Dobbin KK, Lively T, Jacobson JW, Beer DG (2008) Gene expression-based survival prediction in lung adenocarcinoma: a multi-site blinded validation study. Nat Med 14:822\u2013827","journal-title":"Nat Med"},{"key":"9785_CR31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/365170a0","volume":"365","author":"D Spengler","year":"1993","unstructured":"Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg PH, Journot L (1993) Differential signal transduction by five splice variants of the PACAP receptor. Nature 365:170\u2013175","journal-title":"Nature"},{"key":"9785_CR32","doi-asserted-by":"crossref","first-page":"31261","DOI":"10.1074\/jbc.274.44.31261","volume":"274","author":"JA Tapia","year":"1999","unstructured":"Tapia JA, Ferris HA, Jensen RT, Garcia LJ (1999) Cholecystokinin activates PYK2\/CAK\u03b2 by a phospholipase C-dependent mechanism and its association with the mitogen-activated protein kinase signaling pathway in pancreatic acinar cells. J Biol Chem 274:31261\u201331271","journal-title":"J Biol Chem"},{"key":"9785_CR33","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/sj.onc.1203422","volume":"19","author":"N Wittau","year":"2000","unstructured":"Wittau N, Grosse R, Kalkbrenner F, Gohla A, Schultz G, Gudermann T (2000) The galanin receptor type 2 initiates multiple signaling pathways in small cell lung cancer cells by coupling to Gq, Gi and G12 proteins. Oncogene 19:1318\u20131328","journal-title":"Oncogene"},{"key":"9785_CR34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.lungcan.2008.05.008","volume":"62","author":"S Zhang","year":"2008","unstructured":"Zhang S, Qiu X, Gu Y, Wang E (2008) Up-regulation of proline-rich tyrosine kinase 2 in non-small cell lung cancer. Lung Cancer 62:295\u2013301","journal-title":"Lung Cancer"},{"key":"9785_CR35","first-page":"4886","volume":"55","author":"F Zia","year":"1995","unstructured":"Zia F, Fagarasan M, Bitar K, Coy DH, Pisegna J, Wank S, Moody TW (1995) PACAP receptors regulate the growth of non-small cell lung cancer cells. Cancer Res 55:4886\u20134891","journal-title":"Cancer Res"},{"key":"9785_CR36","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/sj.onc.1203422","volume":"19","author":"S Zrihan-Licht","year":"2000","unstructured":"Zrihan-Licht S, Fu Y, Settleman J, Schinkmann K, Shaw L, Keydar I, Avraham S, Avraham H (2000) RAFTK\/PYK2 tyrosine kinase mediates the association of P190 RhoGAP with RasGAP and is involved in breast cancer cell invasion. Oncogene 19:1318\u201328","journal-title":"Oncogene"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-012-9785-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-012-9785-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-012-9785-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T15:43:19Z","timestamp":1561736599000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-012-9785-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,12]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["9785"],"URL":"https:\/\/doi.org\/10.1007\/s12031-012-9785-6","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,12]]}}}